Raymond James Financial Inc. Invests $57,000 in AbCellera Biologics Inc. (NASDAQ:ABCL)
Raymond James Financial Inc. bought a new position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 19,501 shares of the company’s stock, valued at approximately $57,000. A number of other large investors have also added to or reduced their stakes in the business. […]
Raymond James Financial Inc. bought a new position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 19,501 shares of the company’s stock, valued at approximately $57,000. A number of other large investors have also added to or reduced their stakes in the business. […]
